-
1 Comment
BML, Inc is currently in a long term uptrend where the price is trading 11.2% above its 200 day moving average.
From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
BML, Inc's total revenue rose by 24.3% to $38B since the same quarter in the previous year.
Its net income has increased by 195.0% to $5B since the same quarter in the previous year.
Based on the above factors, BML, Inc gets an overall score of 4/5.
| ISIN | JP3799700004 |
|---|---|
| Industry | Diagnostics & Research |
| Exchange | TSE |
| CurrencyCode | JPY |
| Sector | Healthcare |
| Target Price | 4200 |
|---|---|
| Dividend Yield | 2.8% |
| Market Cap | 132B |
| PE Ratio | 21.99 |
| Beta | 0.26 |
BML, Inc. provides contract clinical testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing. It also provides contract clinical testing, including endocrine, plasma protein, biochemical, viral, immunoserological, hematological, cellular immunity, bacteriological, and histopathological, pathological, and cytological tests; specimen receiving service; and medical information system services, which include electronic medical charts for clinics without beds. In addition, the company is involved in manufacturing and supply services for medical equipment and supplies; real estate leasing and insurance agency business; providing food hygiene inspection and food consulting services; and dispensing pharmacy services. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4694.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
